- 振東製藥
- 4.430-0.070 (-1.556%)
盈利能力分析
- 0.779
- -0.843
- -0.769
- 38.143
- 4.729
- 0.665
- -0.691
- -0.616
- 29.581
- 3.610
- 0.757
- -0.807
- -0.728
- 34.670
- 4.229
邊際利潤分析
- 50.867
- 50.375
- 49.314
- 59.667
- 62.234
- 2.514
- -0.827
- -0.159
- 61.282
- 6.729
- 2.247
- -1.303
- 0.126
- 61.457
- 7.042
- 1.611
- -1.320
- -1.529
- 51.232
- 5.231
收益指標分析
- -50.343
- 401.713
- 3,667.027
- 2.700
- 79.911
- 72.042
- -119.491
- -1,250.833
- 94.803
- 4.332
- -10.216
- 20.453
- -12.118
- -0.175
- -1.041
償債能力分析
- 5.401
- 4.864
- 4.038
- 4.680
- 2.237
- 3.913
- 3.560
- 3.150
- 4.159
- 1.753
- 13.630
- 16.769
- 20.266
- 20.201
- 0.259
- 0.986
- 1.211
- 2.893
- 4.074
- 9.563
- 9,906.546
- 7,972.653
- 3,282.543
- 2,314.544
- 903.707
- 638.248
- 499.702
- 395.756
- 396.256
- 286.540
- -65.070
- 4.940
- 0.471
- 218.054
- 18.409
營運能力分析
- 77.651
- 66.030
- 76.499
- 71.145
- 82.872
- 276.557
- 227.064
- 191.597
- 154.396
- 139.506
回顧24 展望25
大國博弈
More